Zobrazeno 1 - 10 of 746 pro vyhledávání: '"Am, Scott"'
5
Akademický článek
Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility study.
Autor: Qadir A; Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health Care, Monash University, Melbourne, Australia., Singh N; Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health Care, Monash University, Melbourne, Australia., Dean J; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia., Brown K; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia., Tacey M; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia., Mann B; Royal Women's Hospital, Parkville, VIC, Australia.; Melbourne University, Parkville, VIC, Australia., Kron T; Melbourne University, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Parkville, VIC, Australia., Cahoon G; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia., Lau E; Melbourne University, Parkville, VIC, Australia.; Austin Health, Heidelberg, VIC, Australia.; Department of Molecular Imaging, Austin Health and University of Melbourne, Victoria, Australia., Scott AM; School of Cancer Medicine, Olivia Newton John Cancer Research Instituteand, Latrobe University , Melbourne, VIC, Australia.; Department of Molecular Imaging, Austin Health and University of Melbourne, Victoria, Australia., Yeo B; School of Cancer Medicine, Olivia Newton John Cancer Research Instituteand, Latrobe University , Melbourne, VIC, Australia.; Medical Oncology, Austin Health, Heidelberg, VIC, Australia., Loh SW; Breast Surgery, Austin Health, Heidelberg, VIC, Australia., Uribe S; Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health Care, Monash University, Melbourne, Australia., Moe AAK; Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health Care, Monash University, Melbourne, Australia., Ireland-Jenkins K; Melbourne University, Parkville, VIC, Australia.; Anatomical Pathology, Austin Health, Heidelberg, VIC, Australia., McAuley R; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia., McDermont L; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia., Ooi WM; Breast Surgery, Austin Health, Heidelberg, VIC, Australia., Ng S; Breast Surgery, Austin Health, Heidelberg, VIC, Australia., Chao M; Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health Care, Monash University, Melbourne, Australia.; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia., Foroudi F; Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health Care, Monash University, Melbourne, Australia. farshad.foroudi@austin.org.au.; Department of Radiation Oncology, Newton-John Cancer Wellness and Research Centre, 145 Studley Road, PO Box 5555, Heidelberg , Austin HealthVictoria, Olivia, 3084, Australia. farshad.foroudi@austin.org.au.; School of Cancer Medicine, Olivia Newton John Cancer Research Instituteand, Latrobe University , Melbourne, VIC, Australia. farshad.foroudi@austin.org.au.
Publikováno v: Pilot and feasibility studies [Pilot Feasibility Stud] 2024 Nov 07; Vol. 10 (1), pp. 133. Date of Electronic Publication: 2024 Nov 07.
Zobrazit plný text záznamu
6
Akademický článek
Radiotherapy and theranostics: a Lancet Oncology Commission.
Autor: Abdel-Wahab M; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria. Electronic address: m.abdel-wahab@iaea.org., Giammarile F; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Carrara M; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Paez D; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Hricak H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA; Department of Radiology, Weill Cornell Medical College, New York, NY, USA; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, NY, USA., Ayati N; Centre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia., Li JJ; Centre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia., Mueller M; WifOR Institute, Darmstadt, Germany., Aggarwal A; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK., Al-Ibraheem A; Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan; Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan., Alkhatib S; Department of Radiation Oncology, Henry Ford Health, Detroit, MI, USA., Atun R; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA; Department of Health Policy and Management, Harvard T H Chan School of Public Health, Boston, MA, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Bello A; National Hospital, Abuja and Federal University of Health Sciences, Azare, Nigeria., Berger D; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Delgado Bolton RC; Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja, Logroño, Spain; Servicio Cántabro de Salud, Santander, Spain., Buatti JM; Department of Radiation Oncology, Holden Comprehensive Cancer Center, Carver College of Medicine, University of Iowa, Iowa City, IA, USA., Burt G; University of Lancaster, Lancaster, UK., Bjelac OC; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Cordero-Mendez L; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Dosanjh M; University of Oxford, Oxford, UK; European Organization for Nuclear Research, Geneva, Switzerland., Eichler T; Department of Radiation Oncology, Massey Cancer Center Virginia Commonwealth University, Richmond, VA, USA., Fidarova E; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Gondhowiardjo S; Department of Radiotherapy, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia., Gospodarowicz M; Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada., Grover S; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Hande V; Department of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Harsdorf-Enderndorf E; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Herrmann K; Department of Nuclear Medicine, University of Duisburg, Essen, Germany; German Cancer Consortium, University Hospital Essen, Essen, Germany., Hofman MS; Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Holmberg O; Division of Radiation, Transport and Waste Safety, Department of Nuclear Safety and Security, International Atomic Energy Agency, Vienna, Austria., Jaffray D; Department of Radiation Physics and Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Knoll P; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Kunikowska J; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland., Lewis JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA; Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA., Lievens Y; Department of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium., Mikhail-Lette M; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Ostwald D; WifOR Institute, Darmstadt, Germany; Steinbeis School of International Business and Entrepreneurship, Herrenberg, Germany., Palta JR; Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA., Peristeris P; WifOR Institute, Athens, Greece., Rosa AA; Radiation Oncology, Grupo Oncoclinicas, Salvador, Brazil., Salem SA; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Dos Santos MA; Latin American Society of Radiation Oncology, Brasilia/DF, Brazil., Sathekge MM; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; Steve Biko Academic Hospital, Pretoria, South Africa; Nuclear Medicine Research Infrastructure, Pretoria, South Africa., Shrivastava SK; Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India., Titovich E; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Urbain JL; Department of Radiology, Division of Nuclear Medicine, Branford General Hospital, Ontario, Canada., Vanderpuye V; National Center for Radiotherapy Oncology and Nuclear Medicine Department of the Korlebu Teaching Hospital, Accra, Ghana., Wahl RL; Mallinckrodt Institute of Radiology, Department of Radiology, and Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA., Yu JS; Department of Radiation Oncology and Department of Cancer Biology, Cleveland Clinic, Cleveland, OH USA., Zaghloul MS; Radiation Oncology Department, National Cancer Institute, Cairo University & Children's Cancer Hospital, Cairo, Egypt., Zhu H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Scott AM; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia; Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia. Electronic address: andrew.scott@onjcri.org.au.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Nov; Vol. 25 (11), pp. e545-e580. Date of Electronic Publication: 2024 Sep 30.
Zobrazit plný text záznamu
7
Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89 Zr-labelled CI-8993.
Autor: Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Wichmann CW; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., McDonald AF; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia., Guo N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Rigopoulos A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Huynh N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Vail M; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Allen S; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., O'Keefe GJ; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia., Scott FE; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Soikes R; Curis Inc, Lexington, MA, USA., Angelides S; Curis Inc, Lexington, MA, USA., von Roemeling R; Curis Inc, Lexington, MA, USA., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia. andrew.scott@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia. andrew.scott@onjcri.org.au.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia. andrew.scott@onjcri.org.au., Julienne I; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Burvenich G; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Nov; Vol. 51 (13), pp. 4190-4191.
Zobrazit plný text záznamu
8
Akademický článek
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89 Zr-labelled CI-8993.
Autor: Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Wichmann CW; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., McDonald AF; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia., Guo N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Rigopoulos A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Huynh N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Vail M; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Allen S; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., O'Keefe GJ; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia., Scott FE; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Soikes R; Curis Inc, Lexington, MA, USA., Angelides S; Curis Inc, Lexington, MA, USA., Roemeling RV; Curis Inc, Lexington, MA, USA., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, VIC, 3084, Australia. andrew.scott@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia. andrew.scott@onjcri.org.au.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia. andrew.scott@onjcri.org.au.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Nov; Vol. 51 (13), pp. 3863-3873. Date of Electronic Publication: 2024 Jul 26.
Zobrazit plný text záznamu
9
Akademický článek
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.
Autor: Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia., Osellame LD; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3083, Australia., Rigopoulos A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia., Huynh N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia., Cao Z; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3083, Australia., Hoogenraad NJ; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3083, Australia., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia. andrew.scott@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia. andrew.scott@onjcri.org.au.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3083, Australia. andrew.scott@onjcri.org.au.; Department of Medicine, University of Melbourne, Melbourne, VIC, 3052, Australia. andrew.scott@onjcri.org.au.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Nov; Vol. 51 (13), pp. 3854-3862. Date of Electronic Publication: 2024 Jul 26.
Zobrazit plný text záznamu
10
Akademický článek
Telehealth versus face-to-face delivery of speech language pathology services: A systematic review and meta-analysis.
Autor: Scott AM; Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia., Clark J; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia., Cardona M; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia., Atkins T; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia., Peiris R; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia., Greenwood H; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia., Wenke R; Gold Coast Health, Southport, Queensland, Australia., Cardell E; School of Allied Health Services, Griffith University, Ipswich, Queensland, Australia., Glasziou P; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia.
Publikováno v: Journal of telemedicine and telecare [J Telemed Telecare] 2024 Oct 10, pp. 1357633X241272976. Date of Electronic Publication: 2024 Oct 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje